Pilot Project of Familial Hypercholesterolemia Screening in Newborns in the Czech Republic

NCT05638022 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2022-12-06

No results posted yet for this study

Summary

The project is a national, prospective, multicenter, non-interventional pilot project of screening for the disease Familial hypercholesterolaemia (FH) in newborns in the Czech Republic.

The main goal of the project is to methodically prepare, implement and evaluate a pilot project that will verify the suitability of the proposed procedure of early detection of Familial hypercholesterolaemia in such a way as to ensure the maximum positive impact on the health of the population and high cost-effectiveness of the whole process.

Conditions

  • Familial Hypercholesterolaemia

Interventions

DIAGNOSTIC_TEST

Total cholesterol (TC) level test and direct Low density lipoprotein cholesterol (LDL-C) level test

Total cholesterol (TC) level testing and direct Low density lipoprotein cholesterol (LDL-C) level testing will be performed in all 10,000 newborns enrolled in the project.

DIAGNOSTIC_TEST

DNA testing

DNA testing (NGS analysis of DNA mutations in 9 genes: LDLR, APOB, APOE, PCSK9, LDLRAP1, STAP1, ABCG5, ABCG8, LIPA and polygenic markers) will be performed in the subcohort of 1,500 newborns with highest level of Low density lipoprotein cholesterol (LDL-C).

Sponsors & Collaborators

  • Centre of Cardiovascular and Transplantation Surgery, Czech Republic

    collaborator OTHER
  • The Central European Institute of Technology - Masaryk University

    collaborator UNKNOWN
  • Motol University Hospital

    collaborator OTHER
  • Brno University Hospital

    collaborator OTHER
  • Municipal Hospital Ostrava

    collaborator OTHER
  • University Hospital Olomouc

    collaborator OTHER
  • University Hospital Pilsen

    collaborator OTHER
  • Masaryk Hospital in Ústí nad Labem, Regional Health Corporation

    collaborator UNKNOWN
  • Regional Hospital Kolín, Hospital of the Central Bohemian Region

    collaborator UNKNOWN
  • Havlíčkův Brod Hospital

    collaborator UNKNOWN
  • Tomáš Baťa Regional Hospital in Zlín

    collaborator UNKNOWN
  • Hospital of Hospitaller Brothers

    collaborator UNKNOWN
  • Třebíč Hospital

    collaborator UNKNOWN
  • Institute of Health Information and Statistics of the Czech Republic

    lead OTHER_GOV

Principal Investigators

  • Ondřej Májek, PhD · Institute of Health Information and Statistics of the Czech Republic

  • Tomáš Freiberger, Prof. · Centre of Cardiovascular and Transplantation Surgery, Czech Republic

  • Michal Vrablík, Prof. · General University Hospital, Prague

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2022-12-01
Completion
2022-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05638022 on ClinicalTrials.gov